Brief: Basilea Says H1 2023 Total Revenue Of CHF 84.9 Mln Vs CHF 57.6 Mln

Basilea Pharmaceutica AG, Allschwil

15/08/2023 06:22

Aug 15 (Reuters) - Basilea Pharmaceutica Ag Allschwil
 BSLN.S :
    * BASILEA REPORTS STRONG REVENUE AND PROFIT GROWTH IN FIRST
HALF-YEAR 2023
    * BASILEA RECORDED TOTAL REVENUE IN FIRST HALF-YEAR 2023 OF
CHF
84.9 MILLION (H1 2022: CHF 57.6 MILLION)
    * SEES 2023 OPERATING PROFIT TO INCREASE TO CHF 50 - 55
MILLION
AND NET PROFIT TO CHF 41 - 46 MILLION
    * H1 2023 OPERATING PROFIT OF CHF 36.9 MILLION WAS RECORDED
(H1
2022: OPERATING LOSS OF CHF 10.0 MILLION)
    * H1 NET PROFIT OF CHF 31.8 MILLION (H1 2022: NET LOSS OF
CHF12.2
MILLION)
    * SEES FY 2023 TOTAL REVENUE CHF 157 MILLION TO 160 MILLION

Source text for Eikon:  ID:nGNE5ZHfcK 
Further company coverage:  BSLN.S 

 ((Reuters.Briefs@thomsonreuters.com;))